These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33766947)

  • 21. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
    Su YC; Jalalvand F; Thegerström J; Riesbeck K
    Front Immunol; 2018; 9():2530. PubMed ID: 30455693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.
    Santer FR; Malinowska K; Culig Z; Cavarretta IT
    Endocr Relat Cancer; 2010 Mar; 17(1):241-53. PubMed ID: 19966016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of induced sputum and bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease on neutrophil migration in vitro.
    Babusyte A; Jeroch J; Stakauskas R; Stravinskaite K; Malakauskas K; Sakalauskas R
    Medicina (Kaunas); 2010; 46(5):315-22. PubMed ID: 20679746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonistic Pleiotropy in the Bifunctional Surface Protein FadL (OmpP1) during Adaptation of Haemophilus influenzae to Chronic Lung Infection Associated with Chronic Obstructive Pulmonary Disease.
    Moleres J; Fernández-Calvet A; Ehrlich RL; Martí S; Pérez-Regidor L; Euba B; Rodríguez-Arce I; Balashov S; Cuevas E; Liñares J; Ardanuy C; Martín-Santamaría S; Ehrlich GD; Mell JC; Garmendia J
    mBio; 2018 Sep; 9(5):. PubMed ID: 30254117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease.
    Yoshikawa T; Dent G; Ward J; Angco G; Nong G; Nomura N; Hirata K; Djukanovic R
    Am J Respir Crit Care Med; 2007 Mar; 175(5):473-9. PubMed ID: 17110644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
    Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
    Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Airway Bacteria Quantification Using Polymerase Chain Reaction Combined with Neutrophil and Eosinophil Counts Identifies Distinct COPD Endotypes.
    Beech A; Lea S; Li J; Jackson N; Mulvanny A; Singh D
    Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-site placebo-controlled randomised clinical trial to assess protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.
    Clancy RL; Dunkley ML; Sockler J; McDonald CF
    Intern Med J; 2016 Jun; 46(6):684-93. PubMed ID: 27009822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation.
    Grabcanovic-Musija F; Obermayer A; Stoiber W; Krautgartner WD; Steinbacher P; Winterberg N; Bathke AC; Klappacher M; Studnicka M
    Respir Res; 2015 May; 16(1):59. PubMed ID: 25994149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.
    Patel IS; Seemungal TA; Wilks M; Lloyd-Owen SJ; Donaldson GC; Wedzicha JA
    Thorax; 2002 Sep; 57(9):759-64. PubMed ID: 12200518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients.
    Pedersen F; Marwitz S; Holz O; Kirsten A; Bahmer T; Waschki B; Magnussen H; Rabe KF; Goldmann T; Uddin M; Watz H
    Respir Med; 2015 Oct; 109(10):1360-2. PubMed ID: 26321138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease.
    Bresser P; Out TA; van Alphen L; Jansen HM; Lutter R
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):947-52. PubMed ID: 10988111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
    Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
    Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
    Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability and effects of bronchial colonisation in patients with moderate COPD.
    Marin A; Monsó E; Garcia-Nuñez M; Sauleda J; Noguera A; Pons J; Agustí A; Morera J
    Eur Respir J; 2010 Feb; 35(2):295-302. PubMed ID: 19643939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.